Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
MIO
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 100 Added 0.0% |
$1,192
$11.92 p/Share
|
Jan 22
2025 |
|
SCS
|
Robert G Krestakos
VP, Chief Operations Officer |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 4.18% |
$58,700
$11.74 p/Share
|
Jan 22
2025 |
|
VICR
|
Andrew D'Amico
Director |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 100.0% |
$239,000
$59.75 p/Share
|
Jan 22
2025 |
|
COSM
|
Grigorios Siokas
Chief Executive Officer |
BUY
Open market or private purchase
|
Direct | 38,900 Added 0.92% |
$29,953
$0.77 p/Share
|
Jan 22
2025 |
|
ANIX
|
Lewis H Titterton Jr
Director |
BUY
Open market or private purchase
|
Direct | 2,000 Added 0.21% |
$6,020
$3.01 p/Share
|
Jan 22
2025 |
|
SCWO
|
Yaacov Nagar |
SELL
Open market or private sale
|
Direct | 19,772 Reduced 0.05% |
$11,665
$0.59 p/Share
|
Jan 22
2025 |
|
TKO
|
Patrick Whitesell |
BUY
Open market or private purchase
|
Indirect | 115,952 Added 0.0% |
$16,767,818
$144.61 p/Share
|
Jan 22
2025 |
|
TKO
|
Ariel Emanuel
Chief Executive Officer |
BUY
Open market or private purchase
|
Indirect | 115,952 Added 0.0% |
$16,767,818
$144.61 p/Share
|
Jan 22
2025 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 25,931 Reduced 19.12% |
$4,368,076
$168.45 p/Share
|
Jan 22
2025 |
|
NTRA
|
Steven Leonard Chapman
CEO AND PRESIDENT |
SELL
Open market or private sale
|
Direct | 78,553 Reduced 22.69% |
$13,233,038
$168.46 p/Share
|
Jan 22
2025 |
|
NTRA
|
Daniel Rabinowitz
SEC. AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct | 22,039 Reduced 9.19% |
$3,712,469
$168.45 p/Share
|
Jan 22
2025 |
|
NTRA
|
Jonathan Sheena |
SELL
Open market or private sale
|
Direct | 971 Reduced 0.37% |
$163,545
$168.43 p/Share
|
Jan 22
2025 |
|
TKO
|
Silver Lake West Hold Co, L.P. |
BUY
Open market or private purchase
|
Indirect | 115,952 Added 0.0% |
$16,767,818
$144.61 p/Share
|
Jan 22
2025 |
|
TDUP
|
Patricia Nakache |
SELL
Open market or private sale
|
Indirect | 122,837 Reduced 0.0% |
$277,611
$2.26 p/Share
|
Jan 22
2025 |
|
PLMR
|
T Christopher Uchida
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,030 Reduced 5.96% |
$112,939
$109.65 p/Share
|
Jan 22
2025 |
|
DTIL
|
J. Jefferson Smith
Chief Research Officer |
SELL
Open market or private sale
|
Direct | 10,287 Reduced 10.53% |
$49,274
$4.79 p/Share
|
Jan 22
2025 |
|
DTIL
|
Dario Scimeca
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 8,928 Reduced 26.83% |
$42,765
$4.79 p/Share
|
Jan 22
2025 |
|
META
|
Mark Zuckerberg
COB and CEO |
SELL
Open market or private sale
|
Indirect | 35,921 Reduced 0.0% |
$22,536,476
$627.39 p/Share
|
Jan 22
2025 |
|
PNRG
|
Clint Hurt
Director |
SELL
Open market or private sale
|
Direct | 4,894 Reduced 3.72% |
$1,053,286
$215.22 p/Share
|
Jan 22
2025 |
|
PDEX
|
Raymond E Cabillot
Director |
SELL
Open market or private sale
|
Indirect | 2,271 Reduced 0.0% |
$98,061
$43.18 p/Share
|
Jan 22
2025 |
|
WHLM
|
Warren G Lichtenstein
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 4,101 Added 0.0% |
$13,943
$3.4 p/Share
|
Jan 22
2025 |
|
SLAB
|
William G Bock
Director |
SELL
Open market or private sale
|
Direct | 2,000 Reduced 5.86% |
$281,540
$140.77 p/Share
|
Jan 22
2025 |
|
DIS
|
Sonia L Coleman
Sr. EVP and Chief HR Officer |
SELL
Open market or private sale
|
Direct | 689 Reduced 100.0% |
$74,935
$108.76 p/Share
|
Jan 22
2025 |
|
SMC
|
J Heath Deneke
Chairman, President and CEO |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 0.37% |
$42,730
$42.73 p/Share
|
Jan 22
2025 |
|
PLRX
|
Mike Ouimette
General Counsel & Corp. Sec'y |
SELL
Open market or private sale
|
Direct | 10,230 Reduced 12.66% |
$112,427
$10.99 p/Share
|
Jan 22
2025 |
|
FLWS
|
Fund 1 Investments, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 89,301 Added 0.0% |
$748,342
$8.38 p/Share
|
Jan 22
2025 |
|
JRVSD
|
Frank Gillen
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,430,000 Added 21.4% |
$572,000
$0.4 p/Share
|
Jan 22
2025 |
|
JRVSD
|
Yolanda Goodell
CEO |
BUY
Open market or private purchase
|
Direct | 1,430,000 Added 21.41% |
$572,000
$0.4 p/Share
|
Jan 22
2025 |
|
JRVSD
|
Francis Pittilloni
Chief Financial Officer |
BUY
Open market or private purchase
|
Direct | 1,430,000 Added 21.41% |
$572,000
$0.4 p/Share
|
Jan 22
2025 |
|
PSIX
|
Gary S Winemaster
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 17,983 Reduced 0.6% |
$662,493
$36.84 p/Share
|
Jan 21
2025 |
|
CBIO
|
Songjiang Ma
President |
SELL
Open market or private sale
|
Indirect | 2,000 Reduced 0.0% |
$21,700
$10.85 p/Share
|
Jan 21
2025 |
|
NYC
|
Nicholas S Schorsch
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 1,697 Added 0.0% |
$15,612
$9.2 p/Share
|
Jan 21
2025 |
|
W
|
Steven Conine
Co-Founder |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 4.85% |
$1,459,500
$48.65 p/Share
|
Jan 21
2025 |
|
W
|
Niraj Shah
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 30,000 Reduced 4.85% |
$1,457,400
$48.58 p/Share
|
Jan 21
2025 |
|
ABOS
|
Matt Zuga
CFO & Chief Business Officer |
SELL
Open market or private sale
|
Direct | 4,364 Reduced 1.65% |
$6,982
$1.6 p/Share
|
Jan 21
2025 |
|
PAYS
|
Mark Newcomer
CEO |
SELL
Open market or private sale
|
Direct | 61,000 Reduced 0.67% |
$176,290
$2.89 p/Share
|
Jan 21
2025 |
|
SNCY
|
John Gyurci
Chief Acct. Off. & VP, Finance |
SELL
Open market or private sale
|
Direct | 400 Reduced 3.33% |
$6,800
$17.0 p/Share
|
Jan 21
2025 |
|
SNCY
|
David M Davis
President & CFO |
SELL
Open market or private sale
|
Direct | 59,380 Reduced 64.8% |
$1,004,115
$16.91 p/Share
|
Jan 21
2025 |
|
RNA
|
Michael F Mac Lean
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,287 Reduced 3.05% |
$93,975
$28.59 p/Share
|
Jan 21
2025 |
|
RNA
|
Arthur A Levin
Director |
SELL
Open market or private sale
|
Direct | 1,872 Reduced 12.62% |
$53,539
$28.6 p/Share
|
Jan 21
2025 |
|
RNA
|
Sarah Boyce
President and CEO |
SELL
Open market or private sale
|
Direct | 10,397 Reduced 2.99% |
$297,250
$28.59 p/Share
|
Jan 21
2025 |
|
RNA
|
W. Michael Flanagan
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 5,672 Reduced 5.81% |
$162,219
$28.6 p/Share
|
Jan 21
2025 |
|
RNA
|
Teresa Mc Carthy
Chief Human Resources Officer |
SELL
Open market or private sale
|
Direct | 2,959 Reduced 2.74% |
$84,627
$28.6 p/Share
|
Jan 21
2025 |
|
TTD
|
Jeffrey Terry Green
President and CEO |
SELL
Open market or private sale
|
Indirect | 512,953 Reduced 0.0% |
$63,996,016
$124.76 p/Share
|
Jan 21
2025 |
|
RNA
|
Steven George Hughes
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,947 Reduced 4.57% |
$112,884
$28.6 p/Share
|
Jan 21
2025 |
|
RNA
|
Kathleen P. Gallagher
Chief Program Officer |
SELL
Open market or private sale
|
Direct | 3,782 Reduced 6.31% |
$108,127
$28.59 p/Share
|
Jan 21
2025 |
|
SKYH
|
Boston Omaha Corp
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 12,901 Reduced 0.12% |
$146,426
$11.35 p/Share
|
Jan 21
2025 |
|
BPMC
|
Kate Haviland
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 1,446 Reduced 0.96% |
$159,407
$110.24 p/Share
|
Jan 21
2025 |
|
BPMC
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct | 15,161 Reduced 9.05% |
$1,665,890
$109.88 p/Share
|
Jan 21
2025 |
|
BPMC
|
Christina Rossi
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 2,274 Reduced 3.28% |
$251,026
$110.39 p/Share
|
Jan 21
2025 |